Home › Squamous Cell Carcinoma › Illinois
Squamous Cell Carcinoma clinical trials in Illinois
4 studies for Squamous Cell Carcinoma are looking for participants at sites in Illinois.
Cities in Illinois
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- University of Chicago, New Lenox
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06561685Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06669572A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- University of Illinois Cancer Center, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT06064877Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 2, 2025 · NCT06912087From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.